Hyperparathyroidism and Asthenia. A New Deal?
Journal Title: International Journal of Clinical Endocrinology and Metabolism - Year 2017, Vol 3, Issue 1
Abstract
The profile of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptoms and in some cases totally asymptomatic forms. As of 1991, with the increasing frequency of these new forms, several consensus meetings designed to define the criteria for establishing the operability of minimally-symptomatic hyperparathyroidism have been organized [1].
Authors and Affiliations
Sun Fui S Li, Bonnichon P
Keywords
Related Articles
- EP ID EP542530
- DOI 10.17352/ijcem.000028
- Views 59
- Downloads 0
An Analytical Study for Early Diagnosis and Treatment of Infants & Children Suffering From Congenital Hypothyroidism in China
Objective: To study the clinical and laboratory characteristics of children suffering from congenital hypothyroidism in China. Method: 455 cases of congenital hypothyroidism infants were collected from 5 articles were p...
Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App
Diabetes is a major public health issue affecting millions of people in the United States and worldwide. In the United States alone, about 30.3 million people (9.4% of the population) have diabetes [1]. Worldwide, a stag...
Killian-Jamieson Diverticulum Mimicking a Thyroid Tumor
A 42-year-old woman was referred to us for evaluation of a suspicious mass in her left thyroid gland. She had experienced left anterior neck pain and odynophagia for a few weeks. Ultrasonography (US) demonstrated a heter...
Congenital Generalized Lipodystrophy: A Multisystemic Metabolic Disorder
Introduction: Congenital generalized lipodystrophy or Berardinelli-Seip syndrome is a rare autosomal recessive multisystem disorder characterized by the near absence of subcutaneous and visceral adipose tissue from birth...
Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach
Background: Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefits in diabetes. The marketed synthetic DPP...